Saturday, September 28, 2024
HomeTagsBcl-2 Inhibitor

Bcl-2 Inhibitor

EHA 2022 | Ascentage Pharma Releases Encouraging Results of Bcl-2 Inhibitor Lisaftoclax (APG-2575)

Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics